2 Amendments of Jutta HAUG related to 2008/2262(DEC)
Amendment 1 #
Draft opinion
Paragraph 1
Paragraph 1
1. Underlines that the European Medicines Agency's budget is financed both from EU Budget and mainly by fees paid by pharmaceutical industry applicants for obtaining or maintaining a Community marketing authorization. However notes that the EC general contribution increased by 24.48% from 2006 to 2007 and represents 24.13% of the total 2007 revenue; is aware in this context of newly assigned tasks arising from the new Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and an increase in the orphan drugs budget line;
Amendment 2 #
Draft opinion
Paragraph 4
Paragraph 4
4. Encourages the Agency to continue its action in the Orphan Medicines field; discourages, however, the decrease in the Orphan Medicines contribution, mainly due to a change in the policy for orphan fee reductions resulting from the flexibility provided by the Council Regulation (EC) No 1905/2005 on fees, which nonetheless results in (generates) a reduction of 26.25% in 2007 compared to 2006;